Genitourinary/Renal

Clinical Trial NameClinical Trial Full TitlePrincipal InvestigatorProject site statusClinical trials gov number
AGS15E-13-1A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial CancerHotte, Dr Sebastien OpenNCT01963052
AGS-16C3F-15-3A Multi-center, Open Label, Randomized Phase 2 Study of AGS-16C3F vs. Axitinib in Metastatic Renal Cell CarcinomaHotte, Dr Sebastien OpenNCT02639182
BL.12Trial Comparing Nab-Paclitaxel to Paclitaxel in Patients With Advance Urothelial Cancer Progressing on or After Platinum Containing Regimen.Mukherjee, Dr SomOpenNCT02033993
MK-3475-426A Phase III Randomized, Open-label, Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Axitinib versus Sunitinib Monotherapy as a First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma (mRCC) (KEYNOTE-426)Hotte, Dr Sebastien OpenNCT02853331
KEYNOTE 427A Phase II Single-arm, Open-label Monotherapy Clinical Trial of Pembrolizumab (MK-3475) in Advanced Renal Cell Carcinoma (MK-3475-427)Hotte, Dr Sebastien OpenNCT02853344
DANUBEA Phase III, Randomized, Open-label, Controlled, Multi-Center, Global Study of First-Line MEDI4736 Monotherapy and MEDI4736 in Combination with Tremelimumab Versus Standard of Care Chemotherapy in Patients with Unresectable Stage IV Urothelial Bladder CancerMukherjee, Dr SomOpenNCT02516241
IND.223A Phase II Study of Palbociclib, A CDK4/6 Inhibitor, in Patients with Metastatic Castration-Resistant Prostate CancerMukherjee, Dr SomOpenNCT02905318
IND.232A Phase II Study of Durvalumab With or Without Tremelimumab in Patients With Metastatic castration Resistant Prostate CancerHotte, Dr Sebastien OpenNCT02788773
OCOG-2013-PETMUSEImpact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder StagingMukherjee, Dr SomOpenNCT02462239
OCOG-2016-MISTERAssessment of New Molecular Imaging Strategies for Prostate Cancer: Predictive Value of Established and Novel PET Radiotracers in Castration-Resistant Prostate CancerHotte, Dr Sebastien OpenNCT02813226
OZM-053A Phase II, Multi-Centre Study, of Stereotactic Radiotherapy for Oligo-Progression in Renal Cell Cancer Patients Receiving 1st Line Sunitinib TherapySwaminath, Dr AnandOpenNCT02019576
OZM-054A Phase II, randomized, multi-center study of cabazitaxel versus abiraterone or enzalutamide in poor prognosis-metastatic castration-resistant prostate cancerHotte, Dr Sebastien OpenNCT02254785
PR.17RANDOMIZED PHASE 3 TRIAL OF ENZALUTAMIDE IN FIRST LINE ANDROGEN DEPRIVATION THERAPY FOR METASTATIC PROSTATE CANCER: ENZAMETHotte, Dr Sebastien OpenNCT02446405
PACEPACE - International Randomized Study of Laparoscopic Prostatectomy vs Robotic Radiosurgery and Conventionally Fractionated Radiotherapy vs Radiosurgery for Early Stage Organ-Confined Prostate CancerDayes, Dr IanOpenNCT01584258
TOPCOPTOward Personalizing Care for Older men with mCRPC - understanding and predicting treatment toxicities (the TOPCOP study)Hotte, Dr Sebastien OpenNCT02512185
Download PDF